Crossmark

A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes

Crossref DOI link: https://doi.org/10.1038/s41467-022-35544-3

Published Online: 2022-12-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Martin, Alexandra

Mick, Gail J. https://orcid.org/0000-0002-6913-9356
Choat, Heather M. https://orcid.org/0000-0002-9874-1776
Lunsford, Alison A. https://orcid.org/0000-0003-3978-4933
Tse, Hubert M. https://orcid.org/0000-0001-5861-7597
McGwin, Gerald G. Jr.

McCormick, Kenneth L. https://orcid.org/0000-0003-3762-0572
License Information

Text and Data Mining valid from 2022-12-24

Version of Record valid from 2022-12-24
More Information

Article History

Received: 27 October 2021

Accepted: 6 December 2022

First Online: 24 December 2022

Competing interests

: The authors declare no competing interests.

: The protocol and consent documents were approved by the University of Alabama at Birmingham (UAB) Institutional Review Board.

: Written informed consent was obtained from each participant or from the participant’s parent or legal guardian. Also, each participant assented.

Document is current

Any future updates will be listed below